The fourth session of the 13th National People's Congress (NPC) opened in Beijing at 9 am on March 5, marking the start of the "two sessions" in China.A total of 2,900 deputies to the National People's Congress (NPC) stepped into the Great Hall of the People on a mission to attend a spring ceremony.Chairman Fang Tonghua attended this meeting as a representative of the Heilongjiang delegation. Together with other deputies, he performed his duty and pushed the work of the NPC to break new ground in the new era.
Premier Li Keqiang delivered a report on the work of the government on behalf of the State Council, according to the agenda. In his report on the work of the government, Premier Li Keqiang pointed out that China delivered a record performance that satisfied the people, attracted the world's attention and went down in history. At the same time, in the report, the important position and role of traditional Chinese medicine in China's development was once again established by promoting the construction of the health care system, continuing to push forward the Healthy China initiative, putting equal emphasis on traditional Chinese medicine and western medicine, and implementing the major projects for the revitalization and development of traditional Chinese medicine.
It is understood that party with China during the NPC chairman around promotes the development of pharmaceutical industry with high quality, submitted on the construction of traditional Chinese medicine clinical evaluation system and accelerate the quality basic research proposal ", on the management of national basic drugs directory dynamic adjustment suggestion ", the Suggestions for revision < > on the prevention and control of infectious diseases, etc. In the bill, in view of the evaluation system of traditional Chinese medicine, quality control, and basic research, there are some drawbacks in traditional Chinese medicine "generic" controlled drugs, Chinese herbal medicine resources evaluation problems such as weak foundation, proposed party chairman with the China traditional Chinese medicine clinical evaluation system, to set up the Chinese traditional medicine research and reference substance directory, accelerate the classic square resources evaluation platform of Chinese herbal medicine research, such as constructive Suggestions.
In order to improve the direction, policy guidance and practical operation of the National Essential Medicine List, Chairman Fang Tonghua suggested that the restrictions on the dosage forms and specifications of the National Essential Medicine List should be released, and that some provincial-level medicines in the National Essential Medicine List, provincial-level COVID-19 medicines in the TCM prevention and control program list and more Chinese patent medicines should be added to the National Essential Medicine List.